dc.contributor.author |
Simeoni M.C. |
dc.contributor.author |
Auquier P. |
dc.contributor.author |
Fernandez O. |
dc.contributor.author |
Flachenecker P. |
dc.contributor.author |
Stecchi S. |
dc.contributor.author |
Constantinescu C.S. |
dc.contributor.author |
Idiman E. |
dc.contributor.author |
Boyko A.N. |
dc.contributor.author |
Beiske A.G. |
dc.contributor.author |
Vollmer T. |
dc.contributor.author |
Triantafyllou N. |
dc.contributor.author |
O'Connor P. |
dc.contributor.author |
Barak Y. |
dc.contributor.author |
Biermann L. |
dc.contributor.author |
Cristiano E. |
dc.contributor.author |
Atweh S. |
dc.contributor.author |
Patrick D.L. |
dc.contributor.author |
Robitail S. |
dc.contributor.author |
Ammoury N. |
dc.contributor.author |
|
dc.contributor.editor |
|
dc.date |
Mar-2008 |
dc.date.accessioned |
2017-10-05T15:39:10Z |
dc.date.available |
2017-10-05T15:39:10Z |
dc.date.issued |
2008 |
dc.identifier |
10.1177/1352458507080733 |
dc.identifier.isbn |
|
dc.identifier.issn |
13524585 |
dc.identifier.uri |
http://hdl.handle.net/10938/16711 |
dc.description.abstract |
This study aims to validate the Multiple Sclerosis (MS) International Quality of Life (MusiQoL) questionnaire, a multi-dimensional, self-administered questionnaire, available in 14 languages, as a disease-specific quality of life scale that can be applied internationally. A total of 1992 patients with different types and severities of MS from 15 countries were recruited. At baseline and day 21 ± 7, each patient completed the MusiQoL, a symptom checklist and the short-form (SF)-36 QoL questionnaire. Neurologists also collected socio-demographic, MS history and outcome data. The database was randomly divided into two subgroups and analysed according to different patient characteristics. For each model, psychometric properties were tested and the number of items was reduced by various statistical methods. Construct validity, internal consistency, reproducibility and external consistency were also tested. Nine dimensions, explaining 71percent of the total variance, were isolated. Internal consistency and reproducibility were satisfactory for all the dimensions. External validity testing revealed that dimension scores correlated significantly with all SF-36 scores, but showed discriminant validity by gender, socio-economic and health status. Significant correlations were found between activity in daily life scores and clinical indices. These results demonstrate the validity and reliability of the MusiQoL as an international scale to evaluate QoL in patients with MS. © 2008 SAGE Publications Los Angeles, London, New Delhi and Singapore. |
dc.format.extent |
|
dc.format.extent |
Pages: (219-230) |
dc.language |
English |
dc.publisher |
LONDON |
dc.relation.ispartof |
Publication Name: Multiple Sclerosis; Publication Year: 2008; Volume: 14; no. 2; Pages: (219-230); |
dc.relation.ispartofseries |
|
dc.relation.uri |
|
dc.source |
Scopus |
dc.subject.other |
|
dc.title |
Validation of the multiple sclerosis international quality of life questionnaire |
dc.type |
Article |
dc.contributor.affiliation |
Simeoni, M.C., Department of Public Health, Timone University Hospital, Marseille, France |
dc.contributor.affiliation |
Auquier, P., Department of Public Health, Timone University Hospital, Marseille, France, Service de Santé Publique, Faculté de Médecine, 27, bd Jean Moulin, 13385 Marseille, France |
dc.contributor.affiliation |
Fernandez, O., Hospital Regional Universitario Carlos Haya, Málaga, Spain |
dc.contributor.affiliation |
Flachenecker, P., Department of Neurology, University of Würzburg, Würzburg, Germany, Neurological Rehabilitation Center Quellenhof, Bad Wildbad, Würzburg, Germany |
dc.contributor.affiliation |
Stecchi, S., Centro SM, Villa Mazzacorati, Bologna, Italy |
dc.contributor.affiliation |
Constantinescu, C.S., Division of Clinical Neurology, University Hospital, University of Nottingham, Nottingham, United Kingdom |
dc.contributor.affiliation |
Idiman, E., Dokuz Eylül Üniversity, Department of Neurology, Izmir, Turkey |
dc.contributor.affiliation |
Boyko, A.N., Department of Neurology, Russian State Medical University, Moscow, Russian Federation |
dc.contributor.affiliation |
Beiske, A.G., Department of Neurology, Akershus University Hospital, Lørenskog, Norway |
dc.contributor.affiliation |
Vollmer, T., Division of Neurology, Barrow Neurological Institute, Phoenix, AZ, United States |
dc.contributor.affiliation |
Triantafyllou, N., Department of Neurology, Aignition Hospital, University of Athens, Athens, Greece |
dc.contributor.affiliation |
O'Connor, P., St Michael's Hospital, University of Toronto, Toronto, ON, Canada |
dc.contributor.affiliation |
Barak, Y., SHEBA MC, Tel-HaShomer and the Sackler School of Medicine, Tel Aviv, Israel |
dc.contributor.affiliation |
Biermann, L., P.O. Box 12605, Queenswood, South Africa |
dc.contributor.affiliation |
Cristiano, E., Department of Neurology, University of Buenos Aires, Head Neurology Hospital Italiano de Buenos Aires, Buenos Aires, Argentina |
dc.contributor.affiliation |
Atweh, S., Internal Medicine Department, American University of Beirut Medical Center, Beirut, Lebanon |
dc.contributor.affiliation |
Patrick, D.L., Department of Neurology, University of Washington, Seattle, WA, United States |
dc.contributor.affiliation |
Robitail, S., Department of Public Health, Timone University Hospital, Marseille, France |
dc.contributor.affiliation |
Ammoury, N., Serono International S.A., Geneva, Switzerland |
dc.contributor.affiliation |
Beresniak, A., Laboratory of Applied Health Economics LIRAES, University of Paris 5, Paris, France |
dc.contributor.affiliation |
Pelletier, J., Department of Neurology, Timone University Hospital, Marseille, France |
dc.contributor.affiliation |
Edgardo, C. |
dc.contributor.affiliation |
Liliana, P. |
dc.contributor.affiliation |
Jorge, C. |
dc.contributor.affiliation |
Marcela, F. |
dc.contributor.affiliation |
Callegaro, D. |
dc.contributor.affiliation |
Côté, J.-P. |
dc.contributor.affiliation |
Triantafillou, A. |
dc.contributor.affiliation |
Barak, Y. |
dc.contributor.affiliation |
Bloch, I. |
dc.contributor.affiliation |
Reshef, A. |
dc.contributor.affiliation |
Gilad, R. |
dc.contributor.affiliation |
Stecchi, S. |
dc.contributor.affiliation |
Beiske, A. |
dc.contributor.affiliation |
Drulovic, J. |
dc.contributor.affiliation |
Biermann, L. |
dc.contributor.affiliation |
Fernandez, O. |
dc.contributor.affiliation |
Idiman, E. |
dc.contributor.authorAddress |
Auquier, P.; Service de Santé Publique, Faculté de Médecine, 27 bd Jean Moulin, 13385 Marseille, France; email: pascal.auquier@medecine.univ-mrs.fr |
dc.contributor.authorCorporate |
University: American University of Beirut Medical Center; Faculty: Faculty of Medicine; Department: Internal Medicine; Division: Neurology; |
dc.contributor.authorDepartment |
Internal Medicine |
dc.contributor.authorDivision |
Neurology |
dc.contributor.authorEmail |
pascal.auquier@medecine.univ-mrs.fr |
dc.contributor.faculty |
Faculty of Medicine |
dc.contributor.authorInitials |
Simeoni, MC |
dc.contributor.authorInitials |
Auquier, P |
dc.contributor.authorInitials |
Fernandez, O |
dc.contributor.authorInitials |
Flachenecker, P |
dc.contributor.authorInitials |
Stecchi, S |
dc.contributor.authorInitials |
Constantinescu, CS |
dc.contributor.authorInitials |
Idiman, E |
dc.contributor.authorInitials |
Boyko, A |
dc.contributor.authorInitials |
Beiske, AG |
dc.contributor.authorInitials |
Vollmer, T |
dc.contributor.authorInitials |
Triantafyllou, N |
dc.contributor.authorInitials |
O'Connor, P |
dc.contributor.authorInitials |
Barak, Y |
dc.contributor.authorInitials |
Biermann, L |
dc.contributor.authorInitials |
Cristiano, E |
dc.contributor.authorInitials |
Atweh, S |
dc.contributor.authorInitials |
Patrick, DL |
dc.contributor.authorInitials |
Robitail, S |
dc.contributor.authorInitials |
Ammoury, N |
dc.contributor.authorInitials |
Beresn |
dc.contributor.authorOrcidID |
|
dc.contributor.authorReprintAddress |
Auquier, P (reprint author), Fac Med Marseille, Serve Sante Publ, 27 bd Jean Moulin, F-13385 Marseille, France. |
dc.contributor.authorResearcherID |
|
dc.contributor.authorUniversity |
American University of Beirut Medical Center |
dc.description.cited |
ADAMANTIOS D, 2001, INTRO LISREL; Auquier P, 2003, SCHIZOPHR RES, V63, P137, DOI 10.1016-S0920-9964(02)00355-9; Benito-Leon J, 2003, DISABIL REHABIL, V25, P1291, DOI 10.1080-09638280310001608591; Benito-Leon J, 2002, EUR J NEUROL, V9, P497, DOI 10.1046-j.1468-1331.2002.00450.x; Calman M., 1988, SOC SCI MED, V27, P927; Campbell DT, 1959, PSYCHOL BULL, V56, P85; Cella DF, 1996, NEUROLOGY, V47, P129; Courts Nancy Fleming, 2004, J Neurosci Nurs, V36, P42; Crane PK, 2006, J CLIN EPIDEMIOL, V59, P478, DOI 10.1016-j.jclinepi.2005.10.007; CRONBACH LJ, 1951, PSYCHOMETRIKA, V16, P297; ERHART M, 2006, QUAL LIFE RES, V113, pA113; Fischer JS, 1999, MULT SCLER J, V5, P251; Fisher W P Jr, 1997, J Outcome Meas, V1, P87; FOLSTEIN MF, 1983, ARCH GEN PSYCHIAT, V40, P812; Ford HL, 2001, CLIN REHABIL, V15, P247, DOI 10.1191-026921501673658108; Ford HL, 2001, DISABIL REHABIL, V23, P516; Freeman JA, 2001, NEUROLOGY, V57, P68; Ganz P A, 1995, Oncology (Williston Park), V9, P61; Gold SM, 2003, MULT SCLER, V9, P404, DOI 10.1191-1352458503ms927oa; Greenhalgh J, 2004, J NEUROL NEUROSUR PS, V75, P577, DOI 10.1136-jnnp.2003.020529; Gruenewald DA, 2004, MULT SCLER, V10, P690, DOI 10.1191-1352458504ms1116rr; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016-0895-4356(93)90142-N; Guy W, 1976, ECDEU ASSESSMENT MAN, P218; HAUSER SL, 1983, NEW ENGL J MED, V308, P173, DOI 10.1056-NEJM198301273080401; Hemmett L, 2004, QJM-INT J MED, V97, P671, DOI 10.1093-qjmed-hch105; Hobart J, 2001, BRAIN, V124, P962, DOI 10.1093-brain-124.5.962; Hu L. T., 1995, STRUCTURAL EQUATION, P76; Janssens ACJW, 2003, MULT SCLER, V9, P397, DOI 10.1191-1352458503ms930oa; Juniper EF, 1996, QUALITY LIFE PHARMAC, P49; Keenan AM, 2007, ARCH PHYS MED REHAB, V88, P88, DOI 10.1016-j.apmr.2006.10.005; KURTZKE JF, 1983, NEUROLOGY, V33, P1444; KURTZKE JF, 1961, NEUROLOGY, V11, P686; Leplege A, 1997, JAMA-J AM MED ASSOC, V278, P47, DOI 10.1001-jama.278.1.47; LINACRE MJ, 1998, USERES GUIDE WINSTEP; Lincoln NB, 2002, J NEUROL NEUROSUR PS, V72, P93, DOI 10.1136-jnnp.72.1.93; MARCH HW, 1998, PSYCHOL BULL, V103, P391; Marrie RA, 2003, MULT SCLER, V9, P621, DOI 10.1191-1352458503ms971oa; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002-ana.1032; McKenna SP, 1997, EUR PSYCHIAT, V12, pS267, DOI 10.1016-S0924-9338(97)89096-7; Meyers AR, 2000, ARCH NEUROL-CHICAGO, V57, P1224, DOI 10.1001-archneur.57.8.1224; Mitchell AJ, 2005, LANCET NEUROL, V4, P556, DOI 10.1016-S1474-4422(05)70166-6; Myers JA, 2003, CLIN REHABIL, V17, P209, DOI 10.1191-0269215503cr602oa; Nortvedt MW, 1999, NEUROLOGY, V53, P1098; Nortvedt MW, 2001, MULT SCLER, V7, P231, DOI 10.1191-135245801680209330; Nortvedt MW, 2003, MULT SCLER, V9, P63, DOI 10.1191-1352458503ms871oa; Nortvedt MW, 2000, NEUROLOGY, V55, P51; NUNNALLY JC, 1994, STAT FDN PSYCHOMETRI, P31; O'Connor P, 2001, NEUROLOGY, V57, P889; Ozakbas S, 2004, J NEUROL SCI, V218, P3, DOI 10.1016-j.jns.2003.09.015; Pascoe G C, 1983, Eval Program Plann, V6, P185, DOI 10.1016-0149-7189(83)90002-2; Pittock SJ, 2004, ARCH NEUROL-CHICAGO, V61, P679, DOI 10.1001-archneur.61.5.679; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002-ana.410130302; PRIETO L, 2003, ACTA PSYCHIAT SCAN S, V416, P24; Riazi A, 2003, MULT SCLER J, V9, P411, DOI 10.1191-1352458503ms929oa; Robitail S, 2007, QUAL LIFE RES, V16, P1335, DOI 10.1007-s11136-007-9241-1; Samsa G, 1999, PHARMACOECONOMICS, V15, P141, DOI 10.2165-00019053-199915020-00003; Schmidt EZ, 2005, J NEURAL TRANSM, V112, P1201, DOI 10.1007-s00702-005-0275-7; Schwid SR, 2002, NEUROLOGY, V58, P1294; *SCI SOFTW INT, 2001, LIFR SOFTW LISREL 8; Solari Alessandra, 2005, Health Qual Life Outcomes, V3, P16, DOI 10.1186-1477-7525-3-16; Solari A, 1999, J NEUROL NEUROSUR PS, V67, P158, DOI 10.1136-jnnp.67.2.158; Somerset M, 2001, Health Expect, V4, P29, DOI 10.1046-j.1369-6513.2001.00111.x; Somerset M, 2003, QUAL LIFE RES, V12, P21, DOI 10.1023-A:1022088203586; Spilker B, 1996, QUALITY LIFE PHARMAC, P1; Tabachnik B. G., 2001, USING MULTIVARIATE S; VICKREY BG, 1995, QUAL LIFE RES, V4, P187, DOI 10.1007-BF02260859; Visschedijk MAJ, 2004, NEUROLOGY, V63, P2046; Ware JE, 1997, MAP R WINDOWS MULTIT; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097-00005650-199206000-00002; Wright BD, 1979, BEST TEST DESIGN RAS |
dc.description.citedCount |
41 |
dc.description.citedTotWOSCount |
40 |
dc.description.citedWOSCount |
40 |
dc.format.extentCount |
12 |
dc.identifier.articleNo |
|
dc.identifier.coden |
MUSCF |
dc.identifier.pubmedID |
17942521 |
dc.identifier.scopusID |
43149122517 |
dc.identifier.url |
|
dc.publisher.address |
1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND |
dc.relation.ispartofConference |
|
dc.relation.ispartofConferenceCode |
|
dc.relation.ispartofConferenceDate |
|
dc.relation.ispartofConferenceHosting |
|
dc.relation.ispartofConferenceLoc |
|
dc.relation.ispartofConferenceSponsor |
|
dc.relation.ispartofConferenceTitle |
|
dc.relation.ispartofFundingAgency |
|
dc.relation.ispartOfISOAbbr |
Mult. Scler. J. |
dc.relation.ispartOfIssue |
2 |
dc.relation.ispartOfPart |
|
dc.relation.ispartofPubTitle |
Multiple Sclerosis |
dc.relation.ispartofPubTitleAbbr |
Mult. Scler. |
dc.relation.ispartOfSpecialIssue |
|
dc.relation.ispartOfSuppl |
|
dc.relation.ispartOfVolume |
14 |
dc.source.ID |
WOS:000254216600011 |
dc.type.publication |
Journal |
dc.subject.otherAuthKeyword |
International |
dc.subject.otherAuthKeyword |
Multiple sclerosis |
dc.subject.otherAuthKeyword |
MusiQol |
dc.subject.otherAuthKeyword |
Quality of life |
dc.subject.otherAuthKeyword |
Questionnaire |
dc.subject.otherAuthKeyword |
Validation |
dc.subject.otherChemCAS |
|
dc.subject.otherIndex |
adult |
dc.subject.otherIndex |
aged |
dc.subject.otherIndex |
article |
dc.subject.otherIndex |
clinical assessment tool |
dc.subject.otherIndex |
correlation analysis |
dc.subject.otherIndex |
daily life activity |
dc.subject.otherIndex |
demography |
dc.subject.otherIndex |
disease severity |
dc.subject.otherIndex |
female |
dc.subject.otherIndex |
health care quality |
dc.subject.otherIndex |
health status |
dc.subject.otherIndex |
human |
dc.subject.otherIndex |
internal consistency |
dc.subject.otherIndex |
internal validity |
dc.subject.otherIndex |
major clinical study |
dc.subject.otherIndex |
male |
dc.subject.otherIndex |
multiple sclerosis |
dc.subject.otherIndex |
Multiple sclerosis International Quality of Life Questionnaire |
dc.subject.otherIndex |
outcome assessment |
dc.subject.otherIndex |
psychometry |
dc.subject.otherIndex |
quality of life |
dc.subject.otherIndex |
questionnaire |
dc.subject.otherIndex |
reliability |
dc.subject.otherIndex |
reproducibility |
dc.subject.otherIndex |
Short Form 36 |
dc.subject.otherIndex |
social status |
dc.subject.otherIndex |
validity |
dc.subject.otherIndex |
Female |
dc.subject.otherIndex |
Health Status |
dc.subject.otherIndex |
Humans |
dc.subject.otherIndex |
Male |
dc.subject.otherIndex |
Multiple Sclerosis |
dc.subject.otherIndex |
Psychometrics |
dc.subject.otherIndex |
Quality of Life |
dc.subject.otherIndex |
Questionnaires |
dc.subject.otherIndex |
Reproducibility of Results |
dc.subject.otherIndex |
Sensitivity and Specificity |
dc.subject.otherIndex |
World Health |
dc.subject.otherKeywordPlus |
DISABILITY STATUS SCALE |
dc.subject.otherKeywordPlus |
DIAGNOSTIC-CRITERIA |
dc.subject.otherKeywordPlus |
OUTCOME MEASURE |
dc.subject.otherKeywordPlus |
HEALTH-STATUS |
dc.subject.otherKeywordPlus |
MS |
dc.subject.otherKeywordPlus |
PEOPLE |
dc.subject.otherKeywordPlus |
GUIDELINES |
dc.subject.otherKeywordPlus |
VALIDITY |
dc.subject.otherKeywordPlus |
IMPACT |
dc.subject.otherKeywordPlus |
SCHIZOPHRENIA |
dc.subject.otherWOS |
Clinical Neurology |